Lepu Medical Technology (Beijing) Co (300003.SZ) Stock Price

Lepu Medical Technology (Beijing) Co Price

🇨🇳SZSE·CLOSED
11.88CNY
Market closed
Today +/-
Today %

Lepu Medical Technology (Beijing) Co (300003.SZ) Stock | ISIN CNE100000H44. The current Lepu Medical Technology (Beijing) Co stock price is 11.88 CNY (2026). Revenue is 7.7 B CNY. Net income is 1.34 B CNY. The P/E ratio is 16.36. Market capitalization is 21.96 B CNY. Lepu Medical Technology (Beijing) Co operates in the Health sector.

Over the last 18 years Lepu Medical Technology (Beijing) Co grew revenue by 21.8% annually, reaching 6.1 B CNY. Earnings per share have grown at 0.1% per year over the last 18 years. For Lepu Medical Technology (Beijing) Co, the net margin of 4% is down versus 22.4% a few years ago. At today's price the dividend yield works out to roughly 3.98%. The payout ratio is around 23% of earnings. The dividend has grown at 10% per year over the past 14 years.

Lepu Medical Technology (Beijing) Co stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Lepu Medical Technology (Beijing) Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Lepu Medical Technology (Beijing) Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Lepu Medical Technology (Beijing) Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Lepu Medical Technology (Beijing) Co Stock Price History
DateLepu Medical Technology (Beijing) Co Price
Access this data via the Eulerpool API
Get Free API Key

Lepu Medical Technology (Beijing) Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
175.3 M CNY
79.8 M CNY
63.6 M CNY
Jan 1, 2007
299 M CNY
144.7 M CNY
149.7 M CNY
Jan 1, 2008
393.9 M CNY
197.8 M CNY
201.4 M CNY
Jan 1, 2009
565.2 M CNY
320.9 M CNY
292.2 M CNY
Jan 1, 2010
770.1 M CNY
446.8 M CNY
410.5 M CNY
Jan 1, 2011
919.8 M CNY
505.7 M CNY
473.2 M CNY
Jan 1, 2012
1.02 B CNY
434.5 M CNY
403.3 M CNY
Jan 1, 2013
1.3 B CNY
403.3 M CNY
361.6 M CNY
Jan 1, 2014
1.67 B CNY
504.3 M CNY
423.2 M CNY
Jan 1, 2015
2.77 B CNY
704 M CNY
520.9 M CNY
Jan 1, 2016
3.47 B CNY
926.4 M CNY
679.3 M CNY
Jan 1, 2017
4.54 B CNY
1.29 B CNY
899.1 M CNY
Jan 1, 2018
6.36 B CNY
1.74 B CNY
1.22 B CNY
Jan 1, 2019
7.8 B CNY
2.26 B CNY
1.73 B CNY
Jan 1, 2020
8.04 B CNY
2.1 B CNY
1.8 B CNY

Lepu Medical Technology (Beijing) Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 21, 2026, 5:03 AM
 
REVENUE (B CNY)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B CNY)
NET INCOME (B CNY)
NET INCOME GROWTH (%)
DIV. (CNY)
DIV. GROWTH (%)
SHARES (B)
DOCUMENTS
202020212022202320242025e2026e2027e
8.0410.6610.617.986.16.787.78.85
3.1232.61-0.47-24.79-23.5111.0113.6814.87
66.9160.9262.162.6458.1252.3546.0540.09
5.386.496.5953.553.553.553.55
1.81.722.21.260.251.111.341.59
4.41-4.5528.1-42.87-80.4535021.2318.11
0.20.230.280.340.470.30.160.19
17.651521.7421.4338.24-36.17-46.6718.75
1.781.811.821.861.851.851.851.85
––––––––
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Lepu Medical Technology (Beijing) Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Lepu Medical Technology (Beijing) Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Lepu Medical Technology (Beijing) Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Lepu Medical Technology (Beijing) Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Lepu Medical Technology (Beijing) Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Lepu Medical Technology (Beijing) Co stock margins

The Lepu Medical Technology (Beijing) Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lepu Medical Technology (Beijing) Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lepu Medical Technology (Beijing) Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
69.94 %
45.52 %
36.28 %
Jan 1, 2007
75.05 %
48.39 %
50.07 %
Jan 1, 2008
78.52 %
50.22 %
51.13 %
Jan 1, 2009
81.79 %
56.78 %
51.7 %
Jan 1, 2010
82.61 %
58.02 %
53.3 %
Jan 1, 2011
81.42 %
54.98 %
51.45 %
Jan 1, 2012
77.91 %
42.77 %
39.7 %
Jan 1, 2013
68.88 %
30.94 %
27.74 %
Jan 1, 2014
63.43 %
30.22 %
25.36 %
Jan 1, 2015
55.2 %
25.43 %
18.81 %
Jan 1, 2016
60.82 %
26.72 %
19.59 %
Jan 1, 2017
67.19 %
28.43 %
19.81 %
Jan 1, 2018
72.66 %
27.4 %
19.17 %
Jan 1, 2019
72.15 %
28.98 %
22.13 %
Jan 1, 2020
66.9 %
26.12 %
22.42 %

Lepu Medical Technology (Beijing) Co Stock Revenue, EBIT, Earnings per Share

The Lepu Medical Technology (Beijing) Co earnings per share therefore indicates how much revenue Lepu Medical Technology (Beijing) Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
0.36 CNY
0.16 CNY
0.13 CNY
Jan 1, 2007
0.25 CNY
0.12 CNY
0.12 CNY
Jan 1, 2008
0.27 CNY
0.14 CNY
0.14 CNY
Jan 1, 2009
0.38 CNY
0.21 CNY
0.19 CNY
Jan 1, 2010
0.47 CNY
0.28 CNY
0.25 CNY
Jan 1, 2011
0.57 CNY
0.31 CNY
0.29 CNY
Jan 1, 2012
0.63 CNY
0.27 CNY
0.25 CNY
Jan 1, 2013
0.8 CNY
0.25 CNY
0.22 CNY
Jan 1, 2014
1.03 CNY
0.31 CNY
0.26 CNY
Jan 1, 2015
1.7 CNY
0.43 CNY
0.32 CNY
Jan 1, 2016
2 CNY
0.53 CNY
0.39 CNY
Jan 1, 2017
2.55 CNY
0.72 CNY
0.5 CNY
Jan 1, 2018
3.57 CNY
0.98 CNY
0.68 CNY
Jan 1, 2019
4.41 CNY
1.28 CNY
0.98 CNY
Jan 1, 2020
4.52 CNY
1.18 CNY
1.01 CNY

Lepu Medical Technology (Beijing) Co business model & stock analysis

Lepu Medical Technology Beijing Co Ltd was founded in 1999 and is a China-based company specializing in medical devices. The company is headquartered in Beijing and has branches and partners in over 70 countries worldwide. Business Model Lepu Medical's business model is based on the development, production, and distribution of medical devices and consumables. The company is divided into various divisions operating in the field of medical technology, including Cardiovascular, Neurovascular, Structural Heart, Peripheral Vascular, Interventional Oncology, and Infection Control. Products Lepu's products include a wide range of medical devices and consumables for various medical fields. In the Cardiovascular field, the company offers stents, balloon catheters, guide catheters, and vascular closure devices for peripheral vessels, cardiac surgery, and interventional cardiology. In the Neurovascular field, the company provides devices for the treatment of strokes that can dissolve blood clots in the brain. In the Structural Heart field, the company offers pericardial closure systems for minimally invasive treatment of heart defects. The Peripheral Vascular field includes devices for the treatment of diseases in other vessels in the body, such as the legs. Interventional Oncology involves devices for the treatment of cancer through targeted injection of chemotherapy or radioisotopes directly into the tumor. The Infection Control division includes medical devices and consumables for preventing infections during surgical procedures. History Lepu Medical Technology Beijing Co Ltd was founded in 1999 as a distributor of medical devices and consumables. In subsequent years, Lepu developed its own medical devices, laying the foundation for the company's success. In 2009, the company went public on the Shenzhen Stock Exchange. In the same year, Lepu introduced its first newly developed product, a stent for the treatment of peripheral vascular disease, to the Chinese market. Since then, Lepu Medical Technology Beijing Co Ltd has driven continuous expansion through product optimization and strategic acquisitions. Conclusion Lepu Medical Technology Beijing Co Ltd has established itself in the market for medical devices and consumables through its innovative products and constant expansion. The company is divided into various divisions specializing in specific medical fields. The wide range of products offered by the company has made it a significant player in the international market.

Lepu Medical Technology (Beijing) Co SWOT Analysis

Strengths

Lepu Medical Technology Beijing Co Ltd has several strengths that contribute to its competitive advantage in the market. These strengths include:

  • Advanced Technology: Lepu Medical Technology is known for its innovative and cutting-edge medical devices and technologies, which allow them to offer high-quality healthcare solutions to their customers.
  • Strong Research and Development (R&D) Capabilities: The company invests heavily in R&D to continuously improve its product offerings and stay ahead of the competition. This helps them meet the evolving needs of the healthcare industry.
  • Established Brand Image: Lepu Medical Technology has built a strong brand reputation and has gained the trust of healthcare professionals and consumers.
  • Wide Product Portfolio: The company offers a diverse range of medical devices and equipment, providing them with a competitive edge in serving different segments of the healthcare market.

Weaknesses

Despite its strengths, Lepu Medical Technology also faces certain weaknesses, which may potentially hinder its growth and market competitiveness. These weaknesses include:

  • Dependence on China Market: Lepu Medical Technology heavily relies on the Chinese market for its revenue, which exposes them to risks associated with changes in government policies, economic conditions, and other market factors.
  • Limited Global Presence: Although Lepu Medical Technology has made efforts to expand globally, they still have a relatively smaller international footprint compared to some of their competitors. This limits their market reach and potential growth in certain regions.
  • Increased Competition: The medical technology industry is highly competitive, with numerous local and international players vying for market share. Lepu Medical Technology needs to consistently differentiate itself and offer unique value propositions to stay ahead in the market.

Opportunities

There are several opportunities that Lepu Medical Technology can leverage to further strengthen its market position and drive growth. These opportunities include:

  • Growing Demand for Medical Devices: The increasing prevalence of chronic diseases and the aging population worldwide have created a growing demand for advanced medical devices. Lepu Medical Technology can capitalize on this trend by expanding its product offerings and entering new markets.
  • Investment in Emerging Markets: Lepu Medical Technology can explore untapped emerging markets where healthcare infrastructure and demand for medical devices are rapidly growing. This can help them diversify their revenue sources and reduce dependence on any single market.
  • Strategic Partnerships and Collaborations: Collaborating with other industry players, research institutes, and healthcare providers can open up avenues for Lepu Medical Technology to access new technologies, knowledge, and potential distribution networks.

Threats

In addition to opportunities, Lepu Medical Technology also faces certain threats that may pose challenges to its growth and overall performance. These threats include:

  • Regulatory Challenges: Compliance with various regulations, standards, and certifications in the healthcare industry can be complex and costly. Changes in government regulations or failure to meet compliance requirements can negatively impact Lepu Medical Technology's operations.
  • Intense Competition: The medical technology sector witnesses intense competition, with new entrants and established players constantly striving for market share. Lepu Medical Technology needs to continuously innovate and deliver superior products to stay ahead of the competition.
  • Technological Advancements: Rapid technological advancements in the industry bring both opportunities and threats. Lepu Medical Technology needs to keep pace with technological changes and ensure their products remain relevant and up-to-date.

Lepu Medical Technology (Beijing) Co Eulerpool Fair Value

Lepu Medical Technology (Beijing) Co historical P/E ratio, EBIT multiple, and P/S ratio

Lepu Medical Technology (Beijing) Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Lepu Medical Technology (Beijing) Co shares outstanding

The number of shares was Lepu Medical Technology (Beijing) Co in 2025 — This indicates how many shares 1.848 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
486.7 M base_Shares
Jan 1, 2007
1.21 B base_Shares
Jan 1, 2008
1.46 B base_Shares
Jan 1, 2009
1.5 B base_Shares
Jan 1, 2010
1.62 B base_Shares
Jan 1, 2011
1.62 B base_Shares
Jan 1, 2012
1.62 B base_Shares
Jan 1, 2013
1.62 B base_Shares
Jan 1, 2014
1.62 B base_Shares
Jan 1, 2015
1.62 B base_Shares
Jan 1, 2016
1.74 B base_Shares
Jan 1, 2017
1.78 B base_Shares
Jan 1, 2018
1.78 B base_Shares
Jan 1, 2019
1.77 B base_Shares
Jan 1, 2020
1.78 B base_Shares

Lepu Medical Technology (Beijing) Co Dividend History

16 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.3CNY↓ 37.1%2×
Jun 20, 20250.14CNY↓ 4.9%1/2
Sep 23, 20250.16CNY↑ 20.6%2/2
20240.47CNY↑ 38.8%2×
20230.34CNY↑ 24.0%1×
20220.28CNY↑ 20.6%1×
20210.23CNY↑ 14.0%1×
20200.2CNY↑ 21.2%1×
20190.17CNY↑ 29.9%1×
20180.13CNY↑ 29.6%1×
20170.1CNY↑ 22.5%1×
20160.08CNY↓ 42.9%1×

Lepu Medical Technology (Beijing) Co dividend history and estimates

In 2025, Lepu Medical Technology (Beijing) Co paid a dividend amounting to 0.3 CNY. Dividend means that Lepu Medical Technology (Beijing) Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2010
0.13 CNY
0 CNY
Jan 1, 2011
0.25 CNY
0 CNY
Jan 1, 2012
0.18 CNY
0 CNY
Invalid Date
0.18 CNY
0 CNY
Invalid Date
0.13 CNY
0 CNY
Invalid Date
0.14 CNY
0 CNY
Invalid Date
0.08 CNY
0.08 CNY
Jan 1, 2017
0.1 CNY
0 CNY
Jan 1, 2018
0.13 CNY
0 CNY
Jan 1, 2019
0.17 CNY
0 CNY
Jan 1, 2020
0.2 CNY
0 CNY
Jan 1, 2021
0.23 CNY
0 CNY
Jan 1, 2022
0.28 CNY
0 CNY
Jan 1, 2023
0.34 CNY
0 CNY
Jan 1, 2024
0.47 CNY
0 CNY

Lepu Medical Technology (Beijing) Co dividend payout ratio

In 2025, Lepu Medical Technology (Beijing) Co had a payout ratio of 22.59%. The payout ratio indicates the percentage of the company's profits that Lepu Medical Technology (Beijing) Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2006
22.15 %
Jan 1, 2007
22.15 %
Jan 1, 2008
22.15 %
Jan 1, 2009
22.15 %
Jan 1, 2010
25 %
Jan 1, 2011
43.1 %
Jan 1, 2012
36 %
Jan 1, 2013
40.91 %
Jan 1, 2014
25 %
Jan 1, 2015
21.88 %
Jan 1, 2016
20.51 %
Jan 1, 2017
19.6 %
Jan 1, 2018
18.68 %
Jan 1, 2019
16.84 %
Jan 1, 2020
19.8 %
Price targets and forecasts for Lepu Medical Technology (Beijing) Co are not yet available.

Lepu Medical Technology (Beijing) Co Earnings Estimates

Lepu Medical Technology (Beijing) Co Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
4/26/20240.27CNY2.22 BCNY2024 Q1
4/24/20240.25CNY2.93 BCNY2023 Q4

EESG©

Eulerpool ESG Scorecard© for the Lepu Medical Technology (Beijing) Co stock

49/100
62
Environment
27
Social
59
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions7,300
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees51.91
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Lepu Medical Technology (Beijing) Co shareholder structure

% Name
13.20451%
China Shipbuilding Industry Corporation No.725 Institute
China Shipbuilding Industry Corporation No.725 Institute
12.33946%
Pu (Zhong Jie)
Pu (Zhong Jie)
6.70704%
WP Medical Technologies, Inc.
WP Medical Technologies, Inc.
3.66546%
Beijing Dehou Yimin Investment Management Co., Ltd.
Beijing Dehou Yimin Investment Management Co., Ltd.
2.01476%
Hwabao WP Fund Management Co., Ltd.
Hwabao WP Fund Management Co., Ltd.
1.93958%
Ningbo Houde Yimin Investment Management Co., Ltd.
Ningbo Houde Yimin Investment Management Co., Ltd.
1.41284%
E Fund Management Co. Ltd.
E Fund Management Co. Ltd.
1.03584%
China Southern Asset Management Co. Ltd.
China Southern Asset Management Co. Ltd.
0.61848%
Rosefinch Fund Management Co., Ltd.
Rosefinch Fund Management Co., Ltd.
0.61573%
Wang (Yunyou)
Wang (Yunyou)
...

Lepu Medical Technology (Beijing) Co Executives and Management Board

YW

Ms. Yong Wang

(51)

Chief Financial Officer, Senior Deputy General Manager

Compensation1.7 M CNY
ZW

Mr. Zhanjiang Wei

(52)

Senior Deputy General Manager

Compensation1.7 M CNY
BZ

Mr. Bingfeng Zhang

(44)

Deputy General Manager

Compensation1.53 M CNY
WJ

Ms. Weina Jiang

(45)

Secretary of the Board

Compensation1.44 M CNY
XF

Ms. Xiaoying Feng

(50)

Deputy General Manager

Compensation1.25 M CNY

Frequently asked questions about Lepu Medical Technology (Beijing) Co

Lepu Medical Technology Beijing Co Ltd operates under the business model of designing, developing, manufacturing, and distributing medical devices and equipment. The company specializes in the fields of interventional cardiology, vascular surgery, and cardiac surgery. Lepu Medical focuses on providing innovative and high-quality products to improve patient outcomes and enhance medical professionals' efficacy. By constantly investing in research and development, the company stays at the forefront of medical technology advancements. Lepu Medical's commitment to advancing healthcare solutions and its wide range of offerings make it a leading player in the industry.

All fundamentals and in-depth analysis of Lepu Medical Technology (Beijing) Co

Our stock analysis for Lepu Medical Technology (Beijing) Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lepu Medical Technology (Beijing) Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Revenue→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Net Income→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co P/E→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co P/S→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co EBIT→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Dividend→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Directors Dealings→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Stocks→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Market capitalization→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Debt→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Liabilities→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Equity→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co AAQS→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co Employees→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co ROE→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co ROA→
Lepu Medical Technology (Beijing) Co Stock
Lepu Medical Technology (Beijing) Co ROCE→